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MBoC | ARTICLE

SUMO-targeted ubiquitin ligase (STUbL) Slx5
regulates proteolysis of centromeric histone H3
variant Cse4 and prevents its mislocalization to
euchromatin
Kentaro Ohkunia, Yoshimitsu Takahashia, Alyona Fulpb, Josh Lawrimoreb, Wei-Chun Aua,
Nagesh Pasupalac, Reuben Levy-Myersa,c, Jack Warrena, Alexander Strunnikovd, Richard E. Bakere,
Oliver Kerscherc, Kerry Bloomb, and Munira A. Basraia,*
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Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
20892; bDepartment of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; cBiology
Department, The College of William & Mary, Williamsburg, VA 23187; dGuangzhou Institutes of Biomedicine and
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ABSTRACT Centromeric histone H3, CENP-ACse4, is essential for faithful chromosome segregation. Stringent regulation of cellular levels of CENP-ACse4 restricts its localization to centromeres. Mislocalization of CENP-ACse4 is associated with aneuploidy in yeast and flies and tumorigenesis in human cells; thus defining pathways that regulate CENP-A levels is critical for
understanding how mislocalization of CENP-A contributes to aneuploidy in human cancers.
Previous work in budding yeast shows that ubiquitination of overexpressed Cse4 by Psh1, an
E3 ligase, partially contributes to proteolysis of Cse4. Here we provide the first evidence that
Cse4 is sumoylated by E3 ligases Siz1 and Siz2 in vivo and in vitro. Ubiquitination of Cse4 by
the small ubiquitin-related modifier (SUMO)-targeted ubiquitin ligase (STUbL) Slx5 plays a
critical role in proteolysis of Cse4 and prevents mislocalization of Cse4 to euchromatin under
normal physiological conditions. Accumulation of sumoylated Cse4 species and increased
stability of Cse4 in slx5∆ strains suggest that sumoylation precedes ubiquitin-mediated proteolysis of Cse4. Slx5-mediated Cse4 proteolysis is independent of Psh1, since slx5∆ psh1∆
strains exhibit higher levels of Cse4 stability and mislocalization than either slx5∆ or psh1∆
strains. Our results demonstrate a role for Slx5 in ubiquitin-mediated proteolysis of Cse4 to
prevent its mislocalization and maintain genome stability.
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INTRODUCTION
Centromeres are specialized chromosomal loci that are essential for
faithful chromosome segregation. The kinetochore (centromeric
DNA and associated proteins) provides an attachment site for
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microtubules for segregation of sister chromatids during mitosis.
Despite the wide divergence of centromere DNA sequences, kinetochore proteins such as centromeric histone H3 variant are evolutionarily conserved from yeast to humans (Cse4 in Saccharomyces
cerevisiae, Cnp1 in Schizosaccharomyces pombe, CID in Drosophila,
and CENP-A in mammals) and are essential for chromosome segregation (Kitagawa and Hieter, 2001; Smith, 2002; Biggins, 2013). The
function of CENP-A is also evolutionarily conserved, as budding
yeast Cse4 can rescue a depletion of mammalian CENP-A (Wieland
et al., 2004).
Stringent regulation of CENP-A expression is essential for genome stability. Overexpression of CENP-A causes ectopic mislocalization to chromosome arms and promotes aneuploidy in humans,
flies, and yeast (Scott and Sullivan, 2014). Overexpression and
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mislocalization of CENP-A are observed in many cancers and contribute to tumorigenesis in human cells (Tomonaga et al., 2003;
Amato et al., 2009; Hu et al., 2010; Li et al., 2011; Wu et al., 2012;
Lacoste et al., 2014; Athwal et al., 2015). In flies, mislocalization of
CID causes formation of ectopic kinetochores and leads to mitotic
delays, anaphase bridges, chromosome fragmentation, aneuploidy,
and lethality (Heun et al., 2006). In fission yeast, overexpression of
Cnp1 leads to indiscriminate deposition of Cnp1 at noncentromeric
regions, resulting in growth defects and severe chromosome
missegregation during mitosis and meiosis (Choi et al., 2012;
Castillo et al., 2013; Gonzalez et al., 2014). In budding yeast, mislocalization of Cse4 to euchromatin leads to chromosome segregation defects, and the extent of Cse4 mislocalization directly correlates with the level of chromosome loss (Au et al., 2008). Furthermore,
various pathways involving kinetochore protein Spt4 (Crotti and
Basrai, 2004), histone chaperones Cac1 and Hir1 (Sharp et al.,
2002; Lopes da Rosa et al., 2011), and chromatin remodeler Snf2
(Gkikopoulos et al., 2011) act to prevent the mislocalization of Cse4.
Protein posttranslational modifications, such as ubiquitination
(Kerscher et al., 2006), are important for regulating steady-state levels and preventing mislocalization. For example, proteolysis of CID
prevents its mislocalization to ectopic regions in flies (Heun et al.,
2006; Moreno-Moreno et al., 2011). Proteolysis of CENP-A has also
been observed in senescent human cells or upon infection with herpes simplex virus 1 (Lomonte et al., 2001; Maehara et al., 2010). In
fission yeast, the N-terminus of Cnp1 regulates ubiquitin-mediated
proteolysis of Cnp1 and prevents its mislocalization to ectopic loci
(Gonzalez et al., 2014). In budding yeast, ubiquitin-mediated proteolysis of Cse4 by E3 ubiquitin ligase Psh1 (Hewawasam et al., 2010;
Ranjitkar et al., 2010) and proline isomerase Fpr3 (Ohkuni et al.,
2014) regulates cellular levels of Cse4. Both the N-terminus of Cse4
and the centromere-targeting domain in the C-terminus of Cse4
(which interacts with Psh1) are required for proteolysis of overexpressed Cse4 (Hewawasam et al., 2010; Ranjitkar et al., 2010; Au
et al., 2013). Psh1-mediated proteolysis of Cse4 is also affected by
the facilitates chromatin transcription/transactions (FACT) complex
(Deyter and Biggins, 2014) and phosphorylation of Psh1 by casein
kinase 2 (Hewawasam et al., 2014). Given that Cse4 is not completely stabilized in the psh1∆ mutant, we hypothesize that additional mechanisms regulate proteolysis of Cse4. Identification of
cellular pathways for CENP-A proteolysis is critical for understanding mechanisms that prevent mislocalization of CENP-A and aneuploidy in human cancers.
In addition to ubiquitination, sumoylation is also a critical modifier of chromatin proteins, such as histone H3 (Nathan et al., 2006).
Sumoylation affects several biological processes, including transcription, signal transduction, and genome integrity, by regulating
protein–protein or protein–DNA interactions or by localization and
stability of the interacting proteins (Ulrich, 2009; Gareau and Lima,
2010; Everett et al., 2013; Flotho and Melchior, 2013; Jentsch and
Psakhye, 2013). A recent study showed that the interaction of
CDC48/p97 with sumoylated CENP-A activates rRNA genes in Arabidopsis thaliana (Merai et al., 2014). However, these studies did not
define the sumoylation enzymes or a functional role for sumoylated
CENP-A in chromosome segregation. In budding yeast, the covalent attachment of Smt3, a small ubiquitin-related modifier (SUMO),
to target lysines requires the activity of E3 SUMO ligases such as
Siz1 and Siz2 (Johnson and Gupta, 2001; Takahashi et al., 2001).
SUMO-targeted ubiquitin ligases (STUbLs) link SUMO and ubiquitin
modification pathways and facilitate proteolysis of the substrate.
Slx5 and Slx8, two of at least four STUbLs proteins in S. cerevisiae,
form a heterodimer to mediate SUMO-targeted degradation of
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several proteins, including Mot1 and MATα 2 (Wang and Prelich,
2009; Xie et al., 2010), nuclear Siz1 during mitosis (Westerbeck
et al., 2014), and proteins involved in the DNA damage response
and genome maintenance (Cook et al., 2009; Hickey et al., 2012;
Garza and Pillus, 2013; Sriramachandran and Dohmen, 2014). Slx5,
but not Slx8, has been shown to associate with centromeres, and
slx5∆ and slx8∆ mutants show defects in chromosome segregation
(van de Pasch et al., 2013). Depletion of the human homologue of
Slx5/8, RNF4, also leads to chromosome segregation errors (van de
Pasch et al., 2013), suggesting that the role of Slx5/8 is evolutionarily conserved. The kinetochore substrates targeted and modified
by Slx5/8 have not been identified, and therefore the role of STUbL
proteins in chromosome segregation and genome stability is not
well understood.
Here we provide evidence that Cse4 is sumoylated by SUMO E3
ligases Siz1 and Siz2 in vivo and in vitro and that SUMO modification
of Cse4 regulates its proteolysis. Slx5 plays a critical role in ubiquitin-mediated proteolysis of Cse4 and prevents mislocalization of
Cse4 under normal physiological conditions. Mislocalized Cse4 is
highly stable and is not efficiently degraded in psh1∆ and slx5∆
strains. Our results show that Slx5 regulates ubiquitin-mediated proteolysis of Cse4 to prevent its mislocalization in a Psh1-independent
manner.

RESULTS
Cse4 is sumoylated in vitro and in vivo
Protein posttranslational modifications such as ubiquitination and
sumoylation are important for regulating steady-state levels of cellular proteins (Kerscher et al., 2006; Everett et al., 2013). Although
canonical histones are sumoylated (Nathan et al., 2006), there is no
evidence for sumoylation of Cse4. Optimization of the biochemical
purification of Cse4 allowed us to detect sumoylation of Cse4 in
vivo. We performed a pull down of octahistidine-hemagglutinin
(8His-HA)–tagged Cse4 using nickel-nitrilotriacetic acid (Ni-NTA)
agarose beads and detected SUMO-modified Cse4 by Western blot
analysis with an anti-Smt3 antibody (Figure 1A). Protein levels of
cse4 16KR, in which all lysine (K) residues are mutated to arginine
(R), were greatly increased due to its stabilization, as reported previously (Collins et al., 2004). At least three high–molecular weight
bands were observed after transient overexpression of 8His-HA–
Cse4 in wild-type cells (Figure 1A, long exposure, denoted by arrows). In contrast, these SUMO-modified Cse4 species, which are
visible on wild-type 8His-HA–Cse4, were not detected with vector
alone or 8His-HA–cse4 16KR. These results show that Cse4 is
sumoylated in vivo.
To identify the SUMO E3 ligase responsible for Cse4 sumoylation,
we tested the role of two functionally redundant SUMO E3 ligases,
Siz1 and Siz2, that are responsible for sumoylation of a majority of
substrates (Johnson and Gupta, 2001; Johnson, 2004; Takahashi
et al., 2001; Montpetit et al., 2006; Reindle et al., 2006), including the kinetochore protein Ndc10 and histones H2B and H4 in
S. cerevisiae (Montpetit et al., 2006; Nathan et al., 2006). In vitro
sumoylation assays using purified Cse4 (Supplemental Figure S1)
revealed that Siz1 serves as an E3 for Cse4 sumoylation (Figure 1B).
We tested a siz1∆ siz2∆ mutant to determine the role of Siz1 and
Siz2 in sumoylation of Cse4 in vivo (Figure 1C). We failed to detect
SUMO-modified Cse4 species in the siz1∆ siz2∆ strain compared
with the wild-type strain (Figure 1C, pull down). The lower levels of
input Cse4 in the siz1∆ siz2∆ strain may be due to their slow growth
and/or a defect in transcriptional induction from the GAL promoter
(Figure 1C, input); however, SUMO-modified Cse4 species were not
detected in the siz1∆ siz2∆ strain even upon a longer exposure
Slx5 regulates Cse4 proteolysis
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FIGURE 1: Cse4 is sumoylated by Siz1/2 in vitro and in vivo. (A) Cse4 is sumoylated in vivo. Wild-type strain (BY4741)
transformed with vector (pYES2), pGAL-8His-HA-CSE4 (pMB1345), or pGAL-8His-HA-cse4 16KR (pMB1344) was grown
in raffinose/galactose (2%) for 4 h to induce expression of Cse4. Sumoylation levels of Cse4 and nonmodified Cse4 were
detected using Ni-NTA pull down, followed by Western blot analysis with anti-Smt3 and anti-HA (Cse4) antibodies,
respectively. At least three high molecular weights of 8His-HA–Cse4 (arrows) were detected (Long exposure). Input
samples were analyzed using anti-HA (Cse4) and anti-Tub2 antibodies. Asterisk shows nonspecific sumoylated proteins
that bind to the beads. The mutations of lysine to arginine in 8His-HA–cse4 16KR slightly affect its mobility compared
with wild-type 8His-HA-Cse4. (B) In vitro assay for Cse4 sumoylation. E1 (GST-Uba2/GST-Aos1), E2 (Ubc9), Smt3gg, and
ATP were incubated with or without Siz1∆440. After the reaction, SUMO and SUMO-conjugated Cse4 were detected by
Western blot analysis with anti-Smt3 and anti-Cse4 antibodies, respectively. (C) SUMO E3 ligases Siz1 and Siz2
sumoylate Cse4 in vivo. Wild-type (BY4741) and siz1∆ siz2∆ (YMB7277) strains expressing pGAL-8His-HA-CSE4
(pMB1345) were assayed as described in A. High–molecular weight species of 8His-HA–Cse4 and nonspecific
sumoylated proteins are marked with arrows and an asterisk, respectively.
1502 | K. Ohkuni et al.
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(Figure 1C, long exposure). Our results show that SUMO E3 ligases
Siz1 and Siz2 sumoylate Cse4 in vivo.

The STUbL Slx5 regulates ubiquitin-mediated proteolysis
of Cse4
Previous studies showed that STUbLs link SUMO and ubiquitin
modification pathways to facilitate proteolysis of cellular substrates
(Garza and Pillus, 2013; Sriramachandran and Dohmen, 2014). Slx5,
one of four STUbL proteins (Slx5, Slx8, Uls1, Rad18) in S. cerevisiae,
forms a complex with Siz1 (Westerbeck et al., 2014), and slx5∆
strains exhibit chromosome segregation defects (van de Pasch
et al., 2013). Hence we investigated the role of Slx5 in Cse4 proteolysis. To investigate whether Slx5 interacts with Cse4 in vivo, we
performed a glutathione S-transferase (GST) pull-down assay using a
strain expressing GST-tagged Slx5 and HA-tagged Cse4. Slx5-GST
was affinity purified on glutathione sepharose, and copurifying HACse4 was detected by Western blot analysis with anti-HA antibody
(Figure 2A). Our results show that GST-Slx5 interacts with HA-Cse4
in vivo.
To determine whether Slx5 ubiquitinates Cse4 in vivo, we performed an affinity pull-down assay using agarose with tandem ubiquitin-binding entities (Ub+) from a strain expressing HA-tagged Cse4
(Figure 2B). Ubiquitinated Cse4 was detected as a laddering pattern
in wild-type cells expressing HA-Cse4 but was absent in strains with
vector alone. Faster-migrating Cse4 species (Figure 2B, asterisk)
similar in size to those in the input lane were observed from both
wild-type and slx5∆ strains. These species were also observed in
experiments with wild-type Cse4 and cse4 16KR mutant, in which all
lysines are mutated to arginines (Au et al., 2013; Hewawasam et al.,
2014). Because cse4 16KR cannot be ubiquitinated, this faster-migrating species represents unmodified Cse4, which likely interacts
with ubiquitinated proteins such as canonical histones. The laddering pattern of higher–molecular weight forms of Cse4 was greatly
reduced in an slx5∆ strain (Figure 2B). Quantification of ubiquitinated Cse4 showed a fivefold reduction in high–molecular weight
forms of Cse4 when normalized to input Cse4 in the slx5∆ strain
(Figure 2C). We next investigated whether defects in Cse4 ubiquitination result in increased protein stability in vivo. Overexpressed
HA-tagged Cse4 was transiently induced from a GAL promoter by
the addition of galactose, and cells were shifted to glucose medium
containing cycloheximide (CHX) to inhibit translation. Western blot
analysis with protein extracts from different time points was used to
measure levels of Cse4 after CHX treatment (Figure 2D). HA-Cse4
was rapidly degraded in the wild-type strain (t1/2 = 39.0 min) yet was
stabilized in the slx5∆ strain (t1/2 = 73.2 min). Consistent with this
observation, we detected a similar stabilization of Cse4 in the siz1∆
siz2∆ strain (t1/2 = 74.8 vs. 35.8 min in wild type; Supplemental
Figure S2). Thus we conclude that Slx5 is required for ubiquitination
and proteolysis of Cse4 in vivo.
Because slx5∆ strains show defects in Cse4 ubiquitination and
increased stability of Cse4, we examined whether sumoylated Cse4
accumulates in these strains. We first constructed a strain expressing
His-Flag-tagged Smt3 (HF-Smt3) and Myc-tagged Cse4. HF-Smt3
was purified from cell extracts using Ni-NTA agarose beads, and the
level of sumoylated proteins and sumoylated Cse4 was determined
using anti-Flag (Smt3) and anti-Myc (Cse4) antibodies, respectively.
When Myc-Cse4 was transiently overexpressed, SUMO-modified
Cse4 species were barely detectable in the wild-type strain (Figure
2E, α-Myc). In contrast, the slx5∆ strain showed substantial levels of
sumoylated Cse4, especially high–molecular weight, SUMO- modified Cse4 (Figure 2E, α-Myc). Therefore reduced STUbL activity in
slx5∆ strain contributes to the accumulation of sumoylated Cse4
Volume 27 May 1, 2016

species, suggesting that Slx5-mediated proteolysis is a downstream
consequence of Cse4 sumoylation.
We next examined whether higher levels of sumoylated Cse4
species accumulate in the slx5∆ strain under normal physiological
conditions. Even though sumoylated Cse4 species were detected in
wild-type cells when Cse4 is overexpressed (Figure 1A), we failed to
detect sumoylated Cse4 species in the wild-type strain when Cse4
is expressed from its own promoter (Figure 2F). The failure to detect
sumoylated Cse4 species may be due to low Cse4 expression and/
or ongoing proteolysis of sumoylated Cse4. In contrast, higher levels of sumoylated Cse4 species were clearly observed in the slx5∆
mutant (Figure 2F, arrows). A defect in STUbL activity may in part
contribute to accumulation of polysumoylated (high–molecular
weight) Cse4 species in the slx5∆ strain. Sumoylated Cse4 does not
accumulate in strains deleted for PSH1, an E3-ubiquitin ligase targeting Cse4, or in SIZ1/SIZ2-deleted strains. These results indicate
that lack of STUbL activity in slx5∆ strains contributes to the accumulation of sumoylated Cse4 species under normal physiological
conditions.

Slx5 regulates ubiquitin-mediated proteolysis of Cse4
in a Psh1-independent manner
Previous studies showed that Psh1 interacts with Cse4 and CSE4
overexpression causes growth inhibition in a psh1∆ strain
(Hewawasam et al., 2010; Ranjitkar et al., 2010). Similar to the
growth defect observed for psh1∆ strains, slx5∆ and siz1∆ siz2∆
strains also showed growth inhibition with GAL-CSE4 on galactose
medium (Supplemental Figure S3). Given that Slx5 and Psh1 are
E3 ligases that ubiquitinate Cse4 and that deletion of SLX5 results
in accumulation of sumoylated Cse4 species, we examined
whether Slx5-mediated proteolysis of Cse4 is dependent on Psh1.
We constructed psh1∆ slx5∆ strains using standard yeast mating
and sporulation. The psh1∆ slx5∆ strains do not exhibit growth
defects at 30°C but exhibit a slow-growth phenotype at low (22,
25°C) and high (37°C) temperatures compared with each single
mutant (Supplemental Figure S4A). The psh1∆ slx5∆ strains also
exhibit sensitivity to growth on benomyl (microtubule-depolymerizing agent)–containing plates. Furthermore, psh1∆ slx5∆ strains
exhibit defects in segregation of a reporter chromosome in a colony color assay to measure chromosome transmission fidelity
(Supplemental Figure S4B).
We next analyzed the stability of Cse4 after transient overexpression of HA-Cse4 in wild-type, psh1∆, slx5∆, and psh1∆ slx5∆ strains
(Figure 3A). As expected, deletion of PSH1 or SLX5 moderately
stabilized HA-Cse4 protein levels. In contrast, the double-deletion
mutant psh1∆ slx5∆ showed a dramatic increase in HA-Cse4 protein
stability. The half-life of HA-Cse4 in psh1∆ slx5∆ (t1/2 = 138.6 min) is
twice that of psh1∆ (t1/2 = 77.0 min) or slx5∆ (t1/2 = 69.3 min) strains
(Figure 3B). We next analyzed Cse4 stability in strains expressing
HA-Cse4 from its own promoter. Protein stability assays showed that
Cse4 is rapidly degraded in wild-type cells (t1/2 = 34.7 min), modestly stable in psh1∆ (t1/2 = 46.2 min) and slx5∆ (t1/2 = 53.3 min) single mutants, and highly stable in psh1∆ slx5∆ strain (t1/2 = 77.0 min;
Figure 3, C and D). We conclude that Slx5 regulates ubiquitin-mediated proteolysis of Cse4 independently of Psh1.

Slx5 prevents mislocalization of Cse4 in a Psh1-independent
manner
We investigated the physiological consequence of defects in STUbL
activity by analyzing Cse4 localization in strains expressing Cse4
from its endogenous promoter. Subcellular fractionation and
chromosome spreads were used to examine whether Cse4 was
Slx5 regulates Cse4 proteolysis

| 1503

FIGURE 2: The STUbL Slx5 interacts with Cse4 and regulates ubiquitin-mediated proteolysis of Cse4. (A) Slx5 associates
with Cse4. Expression of pGAL-3HA-CSE4 (pMB1515) and/or pGAL-GST-SLX5 (BOK629) in ubc4∆ ubc6∆ (YOK2501) was
induced by the addition of galactose (2%) for 6 h. Glutathione–Sepharose beads were used for GST-Slx5 pull down, and
the eluate was analyzed by Western blot analysis with anti-HA (Cse4) and anti-GST (Slx5) antibodies. (B) Slx5 regulates
Cse4 ubiquitination. Wild-type (BY4741) and slx5∆ (YMB9035) strains expressing pGAL-3HA-CSE4 (pMB1597) were
grown in raffinose/galactose (2%) for 2 h. Agarose-TUBE1 was used for pull down with tandem ubiquitin-binding entities.
Ubiquitination levels of Cse4 were detected by Western blot analysis with anti-HA antibody, and input samples were
analyzed using anti-HA (Cse4) and anti-Tub2 antibodies. Wild-type (BY4741) strain transformed with vector (pMB433)
was used as a negative control. Asterisk shows nonmodified Cse4. (C) Relative ubiquitination of Cse4 with average
deviation of two biological repeats. Cse4 was normalized using input Cse4 levels. (D) Increased stability of Cse4 in slx5∆
strain. Cse4 expression from pGAL-6His-3HA-CSE4 (pMB1458) in wild-type (BY4741) and slx5∆ (YMB9035) strains was
induced by the addition of galactose (2%) for 2 h. Glucose (2%) containing CHX (10 μg/ml) was added, and cells were
collected at the indicated time points. Blots were probed with anti-HA (Cse4) or anti-Tub2 (loading control) antibody.
Cse4 protein half-life (t1/2) represents the mean of two biological repeats with average deviation. (E) Deletion of SLX5
shows an accumulation of sumoylated Cse4 species. Wild-type (YMB7278) and slx5∆ (YMB7875) strains expressing
pGAL-13Myc-CSE4 (pSB816) were grown in raffinose/galactose (2%) for 4 h. His-Flag–tagged Smt3 (HF-Smt3) was
pulled down by Ni-NTA agarose beads. Cellular levels of sumoylated proteins and sumoylated Cse4 were detected by
1504 | K. Ohkuni et al.
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FIGURE 3: Slx5 regulates Cse4 proteolysis in a Psh1-independent manner. (A) Cse4 expressed from galactose-inducible
promoter is highly stable in psh1∆ slx5∆ strain. Wild-type (BY4741), psh1∆ (YMB9034), slx5∆ (YMB9035), and psh1∆
slx5∆ (YMB9040) strains expressing pGAL-6His-3HA-CSE4 (pMB1458) were assayed as described in Figure 2D.
(B) Kinetics of turnover from A. Cse4 protein half-life (t1/2) is indicated. Error bars in wild type and psh1∆ slx5∆ represent
average deviation of two replicates. (C) Cse4 expressed from its own promoter is moderately stabilized in psh1∆ and
slx5∆ strains and highly stable in psh1∆ slx5∆ strain. Protein extracts were prepared from cells grown to logarithmic
phase in YPD, treated with CHX (20 μg/ml) for various time points, and analyzed by Western blot analysis with anti-HA
(Cse4) or anti-Tub2 (loading control) antibody. Isogenic yeast strains used are wild type (YMB7290), psh1∆ (YMB7393),
slx5∆ (YMB7588), and psh1∆ slx5∆ (YMB7607). (D) Kinetics of turnover from C. Cse4 protein half-life (t1/2) is indicated,
and error bars in wild-type and psh1∆ slx5∆ strains represent average deviation of two replicates.

mislocalized in the slx5∆ strain. These approaches were previously
used to show that defects in ubiquitin-mediated proteolysis of Cse4
in a psh1∆ strain led to the enrichment of Cse4 in chromatin and
mislocalization to euchromatin when Cse4 was overexpressed
(Hewawasam et al., 2010; Ranjitkar et al., 2010; Deyter and Biggins,
2014). Subcellular fractionation of whole-cell lysates was performed
with psh1∆, slx5∆, and psh1∆ slx5∆ strains. Cse4 was barely detectable in the chromatin fraction in a wild-type strain, as its localization

is restricted to centromeres (Figure 4A). In contrast, Cse4 was enriched in chromatin in psh1∆ and slx5∆ strains, and this enrichment
was further enhanced in psh1∆ slx5∆ strains. Similar results were observed for chromatin enrichment of Cse4 transiently overexpressed
from a GAL promoter in psh1∆ and slx5∆ strains, with maximum
enrichment in the psh1∆ slx5∆ strain (Supplemental Figure S5).
These results suggest that Slx5 regulates localization of Cse4 independently of Psh1.

Western blot analysis with anti-Flag (Smt3) and anti-Myc (Cse4) antibodies, respectively. Two different exposures are
shown. (F) Deletion of SLX5, but not PSH1, shows an accumulation of sumoylated Cse4 expressed from its own
promoter. Protein extracts were prepared from cells grown to logarithmic phase in YPD. Sumoylation levels of Cse4 and
nonmodified Cse4 were detected using Ni-NTA pull down, followed by Western blot analysis with anti-Smt3 and anti-HA
(Cse4) antibodies, respectively. Input samples were analyzed using anti-HA (Cse4) and anti-Tub2 antibodies. At least
three high molecular weights of 6His-3HA–Cse4 (arrows) were detected in the slx5∆ strain. Asterisk shows nonspecific
sumoylated proteins that bind to the beads. Isogenic yeast strains used are wild type (YMB7290), slx5∆ (YMB7588),
psh1∆ (YMB7393), and siz1∆ siz2∆ (YMB7611) and untagged strains (BY4742, YMB9034, YMB9035, YMB7277).
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We next used chromosome spreads, a technique that removes
soluble material to visualize localization of chromatin-bound Cse4 in
wild-type, psh1∆, slx5∆, and psh1∆ slx5∆ strains expressing Cse4
from own promoter (Figure 4B). In wild-type cells, Cse4 foci were
restricted to one or two dots, which correspond to kinetochore clusters. In contrast, diffused or multiple foci of Cse4 that overlapped
with the 4′,6-diamidino-2-phenylindole (DAPI)–stained nucleus were
observed in psh1∆ and slx5∆ strains, and this was further exacerbated in psh1∆ slx5∆ cells (Figure 4, B and C). On the basis of these
results, we conclude that Slx5 and Psh1 prevent mislocalization of
Cse4 under normal physiological conditions and that Slx5 regulates
localization of Cse4 in a Psh1-independent manner.

Fluorescence recovery after photobleaching analysis
shows that mislocalized Cse4 is highly stable in psh1∆
and slx5∆ strains
To determine whether the euchromatic pool of mislocalized Cse4
observed in chromosome spreads of slx5∆ and psh1∆ strains is stably incorporated, we performed fluorescence recovery after photobleaching (FRAP) in both mutants. In wild-type strains, Cse4-GFP
signal is restricted to the cluster of 16 kinetochores proximal to the
spindle pole body, and Cse4 incorporated into kinetochores does
not recover after photobleaching (Pearson et al., 2004). In addition
to the kinetochore signal (foci), the nuclei of slx5∆ and psh1∆ strains
show a diffuse fluorescence emanating from noncentromeric regions (haze), consistent with the increased levels of Cse4 in chromatin fractions (Figure 4A) and mislocalization to euchromatin
(Figure 4B). Similar to wild-type cells, the centromere Cse4-GFP foci
in both slx5Δ and psh1Δ cells did not exhibit recovery after photobleaching (Figure 5, A and B). We next examined FRAP of the Cse4GFP haze in slx5Δ and psh1∆ strains. For psh1∆ strains, we imaged
Cse4-GFP haze every 30 s postbleach (Figure 5, B and D); however,
because the Cse4-GFP haze was dimmer in slx5∆, we used only two
Z-series (immediately postbleach and 5 min postbleach) after laser
bleaching to minimize photobleaching from imaging (Figure 5, A and
C). Similar to the centromere Cse4-GFP foci, the Cse4-GFP haze did
not exhibit recovery after photobleaching in either slx5Δ or psh1Δ
cells (Figure 5, C and D). We conclude that the ectopically localized
Cse4 present in slx5Δ and psh1Δ cells, once deposited, is stable.

DISCUSSION

FIGURE 4: Slx5 prevents mislocalization of Cse4 to euchromatin.
(A) Cse4 expressed from its own promoter is increased in chromatin
fraction in psh1∆, slx5∆, and psh1∆ slx5∆ strains. Whole-cell extracts
(WCEs) prepared from equal numbers of logarithmically growing cells
in YPD were fractionated into soluble and chromatin fraction and
assayed by Western blot analysis. Tub2 and histone H3 were used as
markers for soluble and chromatin fractions, respectively. Two blots
shown for Cse4 are indicated (L, long exposure; S, short exposure).
(B, C) Cse4 expressed from its own promoter is mislocalized in psh1∆,
slx5∆, and psh1∆ slx5∆ strains. Chromosome spreads were done by
logarithmically growing cells in YPD. DAPI (blue) and α-HA (red)
staining were used to visualize DNA and Cse4 localization,
respectively. In wild-type strains, Cse4 is predominantly localized to
one or two kinetochore clusters. In mutant strains, mislocalization of
Cse4 is observed as multiple foci or diffused localization throughout
the nucleus. The graph quantifies the number of cells exhibiting Cse4
mislocalization, and error bars are average deviation of two
independent experiments. The number of cells used is indicated (n).
Isogenic yeast strains used are wild type (YMB7290), psh1∆
(YMB7393), slx5∆ (YMB7588), and psh1∆ slx5∆ (YMB7607).
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In this study, we showed that sumoylation and ubiquitination of
Cse4 regulate its proteolysis and prevent its mislocalization. We provide the first evidence for sumoylation of Cse4, by SUMO E3 ligases
Siz1 and Siz2 in vivo and in vitro, and define a role for Slx5 in ubiquitin-mediated proteolysis of Cse4. Slx5-mediated proteolysis of
Cse4 is independent of Psh1, and Cse4 is mislocalized to euchromatin in both psh1∆ and slx5∆ strains under normal physiological conditions. Consistent with these results, Cse4 is highly enriched in the
chromatin fraction and stably incorporated into euchromatin in
psh1∆ and slx5∆ strains. Taken together, our results support a role
for Slx5 in ubiquitination of sumoylated Cse4 to regulate its proteolysis and localization.
Several lines of evidence support the role of Slx5 in proteolysis of
Cse4. Overexpression of CSE4 results in growth inhibition in slx5∆
and siz1∆ siz2∆ strains, similar to psh1∆ strain (Hewawasam et al.,
2010; Ranjitkar et al., 2010; Au et al., 2013). Second, defects in Cse4
ubiquitination observed in slx5∆ strains correlate with an increased
half-life of Cse4 in these strains. Higher stability of Cse4 is also observed in an slx8∆ strain (unpublished data), suggesting that the heterodimeric Slx5/8 STUbL complex is important for Cse4 proteolysis.
Third, deletion of SLX5 leads to accumulation of higher–molecular
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these phenotypes are further exacerbated
in the slx5∆ psh1∆ double mutant. Previous
studies examined Cse4 turnover only in the
context of the kinetochore, where it is stably
incorporated into chromatin (Pearson et al.,
2004). Although the signal is low, the increased levels of noncentromeric Cse4
present in slx5∆ and psh1∆ strains (the
“haze”) enable analysis by FRAP. The apparent stability of mislocalized Cse4 observed
by FRAP suggests that ectopically localized
Cse4 is stably incorporated in the euchromatin; however, it is also possible that the
ectopic Cse4-containing nucleosomes are
dynamic, in equilibrium with (non–fluorescently tagged) H3 in the nucleus (Verdaasdonk et al., 2012). The latter explanation
would require that the exchange mechanism uses a different Cse4/H3 pool than
that under which the Cse4 was initially
misincorporated.
We propose a model (Figure 6) in which
sumoylation and ubiquitination regulate
Cse4 proteolysis to prevent its stable incorporation into euchromatin. At least two independent pathways regulate Cse4 proteolysis. One is dependent on the interaction
of Psh1 with Cse4, which is potentiated by
the nucleosome-destabilizing activity of the
FIGURE 5: Cse4 is stable in euchromatin in slx5∆ and psh1∆ strains. Representative images of
FACT complex. This suggests that Psh1 is
slx5Δ (A) and psh1Δ (B) cells containing Cse4-GFP before (Pre), immediately after (0 min), and
primarily responsible for removing nucleo5 min after photobleaching. Foci correspond to Cse4-GFP enrichment at centromeres. Haze
somal Cse4 at noncentromeric chromatin,
corresponds to Cse4-GFP at euchromatin. Arrows indicate bleached area. Images were
even though the interaction of Psh1 and
compiled using maximum projection. Scale bar, 1 μm. Plots of average normalized intensity of
soluble Cse4 is also reduced in the absence
the bleached area over time for slx5Δ (C) and psh1Δ (D). Integrated intensity was background
subtracted and corrected for photobleaching. Error bars show SD. Bleaching was set at t = 30 s. of FACT (Deyter and Biggins, 2014). The
second pathway, identified here, requires
For slx5Δ, nine cells were used each for foci and haze, and for psh1Δ, eight cells each for foci
sumoylation of Cse4 by Siz1/Siz2 and subseand haze. Isogenic yeast strains used are slx5∆ (YMB9429) and psh1∆ (YMB9430).
quent ubiquitination of Cse4 by Slx5 to
regulate cellular levels of Cse4 and prevent its mislocalization to
weight species of sumoylated Cse4. Similar results for higher levels
euchromatin. Although we do not yet know whether the Siz1/2-Slx5
of sumoylated Mot1, a regulator of TATA-binding protein and depathway acts on soluble Cse4 or chromatin-bound Cse4, together
fects in proteolysis, were observed when SLX5 and/or SLX8 are dethe two pathways act to regulate cellular levels of Cse4 and prevent
leted (Wang and Prelich, 2009). Accumulation of sumoylated Cse4
its mislocalization to euchromatin. Given that mislocalization of
species and increased stability of Cse4 in the slx5∆ strain suggest
Cse4 leads to chromosome segregation defects, it is not surprising
that sumoylation precedes ubiquitin-mediated proteolysis of Cse4.
that cells use multiple ubiquitination pathways for proteolysis of
These phenotypes are not limited to cases in which Cse4 is overexhigh levels of Cse4.
pressed (e.g., using the GAL promoter); higher levels of sumoylated
Unlike Psh1, Slx5 and Slx8 are evolutionarily conserved, and deCse4 and increased stability of Cse4 are also observed under physipletion of the human STUbL orthologue, RNF4, results in defects in
ological conditions when Cse4 is expressed from its own promoter.
chromosome segregation (van de Pasch et al., 2013). Similar to Slx5,
The increased stability of Cse4 in the psh1∆ slx5∆ double mutant compared with either the slx5∆ or psh1∆ single mutant shows
it is possible that RNF4 also regulates the localization of CENP-A and
that Slx5-mediated proteolysis of Cse4 is independent of Psh1 unthat defects in this pathway lead to chromosome missegregation.
Previous studies showed that mislocalization of centromeric histone
der normal physiological conditions. The residual proteolysis of
Cse4 observed in psh1∆ slx5∆ strains suggests that additional pathH3 variants Cse4, Cnp1, and CID contribute to chromosome segregaways/regulators that have yet to be identified also mediate Cse4
tion defects in flies and budding/fission yeast (Heun et al., 2006; Au
proteolysis. This is perhaps not surprising, given that degradation of
et al., 2008; Gonzalez et al., 2014). Thus we propose that the misloexcess of histone H3 is also regulated by at least five E3 ubiquitin
calization of CENP-A contributes to chromosome segregation deligases (Singh et al., 2012). In addition, non–ubiquitin-mediated
fects in slx5∆ and RNF4-depleted cells. These studies are important,
as we do not fully understand how overexpression and mislocalization
pathways partially contribute to Cse4 proteolysis because mutant
of CENP-A observed in many cancers contribute to tumorigenesis.
cse4 16KR, in which all lysines are changed to arginine, is still degraded (Collins et al., 2004; Au et al., 2013).
Our studies on the role of STUbLs in ubiquitin-mediated proteolysis
Endogenously expressed Cse4 is enriched in chromatin fractions
of Cse4 provide mechanistic insights into pathways that prevent mislocalization of CENP-A and aneuploidy in human cancers.
and mislocalized to euchromatin in slx5∆ and psh1∆ strains, and
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GST pull-down assay

FIGURE 6: Model for how Slx5 regulates proteolysis of Cse4 and prevents its mislocalization to
euchromatin. Restricting the localization of Cse4 to centromeric DNA is essential for faithful
chromosome segregation. At least two independent pathways prevent the stable incorporation
of Cse4 into euchromatin. One of these pathways is dependent on the interaction of Psh1 with
Cse4. The second pathway requires sumoylation of Cse4 by Siz1/Siz2 and ubiquitination of
sumoylated Cse4 by Slx5. The two pathways may a) regulate soluble pools of Cse4 to prevent
its mislocalization and/or b) facilitate proteolysis of chromatin-bound Cse4.

MATERIALS AND METHODS
Yeast strains and plasmids
Supplemental Tables S1 and S2 describe the genotype of yeast
strains and plasmids used for this study, respectively.

Sumoylation assay in vivo and in vitro
In vivo sumoylation was assayed in crude yeast extracts using NiNTA agarose beads to pull down His-HA–tagged Cse4 or HisFlag–tagged Smt3 (HF-Smt3) under denaturing condition, as described previously (Ohkuni et al., 2015). In vitro sumoylation
assays were carried out as described previously (Takahashi et al.,
2003). Briefly, the components of the conjugation reaction—
Smt3gg, GST-Uba2, GST-Aos1, Ubc9, and Siz1-Δ440 proteins—
were expressed and purified from Escherichia coli and then used
in the reaction mixture containing Cse4 as a substrate. Cse4 was
produced in E. coli and purified by Sephacryl-S200 chromatography as described (Luger et al., 1997). Substrate (Cse4), E1 (GSTUba2, GST-Aos1), E2 (Ubc9), and SUMO (Smt3gg) were incubated in a total volume 20 μl for 60 min in the presence of 10 mM
ATP, 50 mM Tris-HCl (pH 8.0), 5 mM MgCl2, and 2 mM dithio
threitol at 37˚C. The reaction was stopped by adding 2× Laemmli
buffer.

Protein stability and ubiquitin pull-down assays
Protein stability assay was performed as described previously
(Ohkuni et al., 2014) with some modifications. Cells were grown
to logarithmic phase of growth in a 2% raffinose synthetic complete medium at 25°C. Galactose was added to the medium to a
final concentration of 2% to induce Cse4 expression from the
GAL promoter for 2 h at 25°C. CHX and glucose were then
added to final concentrations of 10 μg/ml and 2%, respectively.
Samples were taken at the indicated time points, and levels of
Cse4 were quantified by Western blot analysis. Protein levels at
each time point were quantified using Gene Tools software (version 3.8.8.0) from SynGene (Frederick, MD). Ubiquitin pull-down
assays were performed by inducing HA-tagged Cse4 from a GAL
promoter by the addition of galactose (2%) for 2 h, as described
previously (Au et al., 2013).
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The ubc4∆ ubc6∆ (YOK 2501) strain was
transformed with pGAL-GST-SLX5 (BOK
629, Open Biosystems Yeast GST Collection YSC4515202484078), pGAL-3HA-CSE4
(pMB 1515), or both pGAL-GST-SLX5
and pGAL-3HA-CSE4. Transformants were
grown in appropriate selective medium with
proline as nitrogen source and 2% sucrose
to logarithmic phase, and then 2% galactose and 0.003% SDS were added to the
cultures and incubation continued for another 6 h. MG132, 75 μM, was added ½ h
before harvesting of the cells. We assayed
200 OD units of yeast cells as described previously (Westerbeck et al., 2014). Whole-cell
extracts (2 OD) and pull down (20 OD) were
analyzed by Western blot analysis.

Subcellular fractionation and
chromosome spreads

Subcellular fractionation to assay chromatin
enrichment of Cse4 was performed as described previously (Au et al., 2008). Cells
were grown to logarithmic phase of growth in 1% yeast extract, 2%
bactopeptone, and 2% glucose (YPD) at 25°C. Chromosome
spreads were performed as described previously (Collins et al.,
2004; Crotti and Basrai, 2004) with some modifications. 16B12
mouse anti-HA antibody (MMS-101P; Covance, Emeryville, CA) was
used as primary antibody at 1:2500 dilution. Cy3-conjugated goat
anti-mouse (115165003; Jackson ImmunoResearch Laboratories,
West Grove, PA) was used as secondary antibody at 1:5000 dilution.
Cells were visualized by DAPI staining (1 μg/ml in phosphate-buffered saline) mounted in antifade mountant (P36935; Molecular
Probes, Eugene, OR). Cells were observed under an Axioskop 2
(Zeiss) fluorescence microscope equipped with a Plan-Apochromat
100× (Zeiss, Thornwood, NY) oil immersion lens. Image acquisition
and processing were performed with the IP Lab version 3.9.9 r3
software (Scanalytics, Fairfax, VA).

Antibodies
Antibodies for experiments were as follows: rabbit polyclonal antiCse4 (Strunnikov laboratory), anti-Tub2 antibodies (Basrai laboratory), anti-HA (12CA5; Roche, Indianapolis, IN), anti-HA (ab9110;
Abcam, Cambridge, MA), anti-myc (A-14; Santa Cruz Biotechnology, Dallas, TX), anti-GST (ab6613; Abcam), anti-Smt3 (y-84; Santa
Cruz Biotechnology), and anti-H3 (ab1791; Abcam). Anti-Cse4 was
used at a dilution of 1:1000, anti-HA was used at a dilution from
1:1000 to 1:10,000, anti-Tub2 and anti-Smt3 were used at 1:3000,
and anti-GST and anti-H3 were used at 1:5000.

FRAP
Strains YMB9430 (Cse4-GFP, psh1Δ) and YMB9429 (Cse4-GFP, slx5Δ)
were grown in YPD to mid logarithmic growth phase before imaging.
Both YMB9430 and YMB9429 were grown at 24° C, but YMB9429
was shifted to 37°C 6 h before imaging. Cells were imaged using a
Nikon Eclipse Ti wide-field inverted microscope with a 100×/1.49
numerical aperture Apo total internal reflection fluorescence objective (Nikon, Melville, NY) and Andor Clara charge-coupled device
camera (Andor, South Windsor, CT) using Nikon NIS Elements imaging software. Photobleaching was performed with a Sapphire 488-50
CDRH laser (Coherent, Santa Clara, CA). A seven-step Z-series with
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200-nm step size with 600-ms exposure time was taken before a 300ms exposure from the laser. Immediately after the laser exposure, a
5-min time lapse with 30-s intervals with the same settings as the first
Z-series was initiated. The Z-series was compiled into single images
using maximum projection, and the integrated intensity of the
bleached area was measured using MetaMorph 7.7 imaging software (Molecular Devices, Sunnyvale, CA). The integrated intensity of
the bleached area had the integrated intensity of the cell background subtracted at each time point, and photobleaching was corrected for by determining the average bleaching rate of a nearby
Cse4-GFP signal and adding back the average signal loss per Z-series. Photobleaching and background subtraction was performed
using Excel (Microsoft, Redmond, WA).

Chromosome transmission fidelity
The chromosome transmission fidelity assay was performed as described previously (Spencer et al., 1990; Ohkuni et al., 2008). Strains
were plated on synthetic medium with limiting adenine and incubated at 25°C for 4 d. Loss of the reporter chromosome results in red
sectors in an otherwise white colony. Colonies that are at least half red
indicate loss of the reporter chromosome in the first cell division.
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SUPPLEMENTAL INFORMATION
Supplemental Figure S1. Purified Cse4 used for in vitro reaction. Coomassie blue
staining of purified Cse4 for in vitro reaction is shown.

Supplemental Figure S2. Deletion of SIZ1 and SIZ2 stabilizes Cse4 protein level in vivo.
Cse4 expression from pGAL-6His-3HA-CSE4 (pMB1458) in wild-type (BY4741) and
siz1∆ siz2∆ (YMB7277) strains was induced by the addition of galactose (2%) for 2 hrs.
Glucose (2%) containing cycloheximide (CHX, 10 µg/ml) was added and cells were
collected at the indicated time points. Blots were probed with anti-HA (Cse4) or antiTub2 (loading control) antibody. Cse4 protein half life (t1/2) represents the mean of two
biological repeats with average deviation.

Supplemental Figure S3. Synthetic dosage lethality of GAL-CSE4 in psh1∆, slx5∆, or
siz1∆ siz2∆ mutants. Wild-type (BY4741), psh1∆ (YMB9034), slx5∆ (YMB9035), and
siz1∆ siz2∆ (YMB7277) strains were transformed with either vector (pMB433) or pGAL6His-3HA-CSE4 (pMB1458). Yeast cells were spotted in 5-fold dilutions on glucose
(2%)- or galactose (2%)- containing synthetic medium selective for vector or GAL-CSE4.
The plates were incubated at 25°C for 4 days and photographed.

Supplemental Figure S4. (A) psh1∆ slx5∆ strains exhibit temperature and benomyl
sensitivities. Cells were spotted in 5-fold dilutions on YPD and YPD supplemented with
benomyl. The plates were incubated at indicated temperatures for 2 days and
photographed. Isogenic yeast strains used are wild-type (BY4741), psh1∆ (YMB9034),

slx5∆ (YMB9035), psh1∆::natR slx5∆::kanMX (YMB9037 and 9038), and
psh1∆::kanMX slx5∆::natR (YMB9039 and 9040). (B) psh1∆ slx5∆ strains exhibit
defects in chromosome transmission fidelity. Chromosome loss was determined by
counting the number of colonies that show loss of the reporter chromosome in the first
division and exhibit a half sector phenotype. Statistical significance was determined by
chi-square test. NS, not significant. Isogenic yeast strains used are wild-type (YMB9378
and 9379), psh1∆ (YMB9425 and 9426), slx5∆ (YMB9375 and 9376), and psh1∆ slx5∆
(YMB9427 and 9428).

Supplemental Figure S5. Cse4 is highly enriched in the chromatin fraction in psh1∆
slx5∆ cells. Wild-type (BY4741), psh1∆ (YMB9034), slx5∆ (YMB9035), and psh1∆
slx5∆ (YMB9040) strains transformed with pGAL-3HA-CSE4 (pMB1597) were used for
subcellular fractionation. Cse4 expression was induced by the addition of galactose (2%)
for 4 hrs. Whole cell extracts (WCE) were fractionated into soluble and chromatin
fractions. Cse4 levels in each fraction were monitored by western blot analysis with antiHA antibody. Tub2 and histone H3 were used as markers for soluble and chromatin
fractions, respectively.

Supplemental Table S1. S. cerevisiae stains used in this study
Strains

Parent

Genotype

Reference

BY4741

MATa his3∆1 leu2∆0 met15∆0 ura3∆0

Open Biosystems

BY4742

MATα his3∆1 leu2∆0 lys2∆0 ura3∆0

Open Biosystems

YMB7277

BY4741/BY4742 MATa siz1∆::kanMX6 siz2∆::kanMX6

This study

YMB7278

BY4741/BY4742 MATa HF-SMT3::LEU2

(Ohkuni et al., 2015)

YMB7290

BY4741/BY4742 MATα cse4∆::kanMX6 [pRS316-6His-3HA-CSE4]

This study

YMB7393

BY4741/BY4742 MATα cse4∆::kanMX6 psh1∆::kanMX6
[pRS316-6His-3HA-CSE4]

This study

YMB7588

BY4741/BY4742 MATα cse4∆::kanMX6 slx5∆::kanMX6
[pRS316-6His-3HA-CSE4]

This study

YMB7607

BY4741/BY4742 MATa cse4∆::kanMX6 psh1∆::kanMX6 slx5∆::kanMX6
[pRS316-6His-3HA-CSE4]

This study

YMB7611

BY4741/BY4742 MATα cse4∆::kanMX6 siz1∆::kanMX6 siz2∆::kanMX6
[pRS316-6His-3HA-CSE4]

This study

YMB7875

BY4741/BY4742 MATa HF-SMT3::LEU2 slx5∆::kanMX6

This study

YMB9034

BY4741

MATa psh1∆::kanMX6

Open Biosystems

YMB9035

BY4741

MATa slx5∆::kanMX6

Open Biosystems

YMB9037

BY4741/BY4742 MATa psh1∆::NatR slx5∆::kanMX6

This study

YMB9038

BY4741/BY4742 MATa psh1∆::NatR slx5∆::kanMX6

This study

YMB9039

BY4741/BY4742 MATa psh1∆::kanMX6 slx5∆::NatR

This study

YMB9040

BY4741/BY4742 MATa psh1∆::kanMX6 slx5∆::NatR

This study

YMB8898

MATa ura3-52 trp1∆63 leu2∆1 lys2-801 his3∆200 473A
Spc29RFP:Hb CSE4∆::6His-GFP-CSE4:mx4NAT

This study

YMB9429

YMB8898

MATa ura3-52 trp1∆63 leu2∆1 lys2-801 his3∆200 473A
Spc29RFP:Hb CSE4∆::6His-GFP-CSE4:mx4NAT
slx5∆::kanMX6

This study

YMB9430

YMB8898

MATa ura3-52 trp1∆63 leu2∆1 lys2-801 his3∆200 473A
Spc29RFP:Hb CSE4∆::6His-GFP-CSE4:mx4NAT
psh1∆::kanMX6

This study

YOK2501

MHY3765

MATα ura3-52 lys2-801 trp1-∆63 his3-∆200
(Westerbeck et al., 2014)
leu2-∆1 ubc4::HIS3 ubc6::TRP1 alpha2::kanMX6

YMB9378

MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63
ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11

F. Holstege

YMB9379

MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63
ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11

F. Holstege

YMB9375

MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63

F. Holstege

ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11
slx5∆::His3MX6
YMB9376

MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63
ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11
slx5∆::His3MX6

F. Holstege

YMB9425

YMB9378

MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63
ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11
psh1∆::kanMX6

This study

YMB9426

YMB9379

MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63
ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11
psh1∆::kanMX6

This study

YMB9427

YMB9375

MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63
ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11
psh1∆::kanMX6 slx5∆::His3MX6

This study

YMB9428

YMB9376

MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63
ura3-52 CFIII (CEN3.L.YPH278) URA3 SUP11
psh1∆::kanMX6 slx5∆::His3MX6

This study

Supplemental Table S2. Plasmids used in this study.
Plasmid

Relevant characteristics

Reference

pYES2

Vector (pGAL, 2µ, URA3)

(Boeckmann et al., 2013)

pMB430

Vector (p425-pGAL1, 2µ, LEU2)

(Mumberg et al., 1994)

pMB433

Vector (p426-pGAL1, 2µ, URA3)

(Mumberg et al., 1994)

pSB816

pRS426-pGAL-13Myc-CSE4 (2µ, URA3)

(Collins et al., 2004)

pRB199

pRS316-6His-3HA-CSE4 (CEN, URA3)

(Boeckmann et al., 2013)

pMB1344

pYES2-pGAL-8His-HA-cse4 16KR (2µ, URA3)

This study

pMB1345

pYES2-pGAL-8His-HA-CSE4 (2µ, URA3)

This study

pMB1458

pMB433-pGAL-6His-3HA-CSE4 (2µ, URA3)

(Au et al., 2013)

pMB1515

pMB430- pGAL-3HA-CSE4 (2µ, LEU2)

This study

pMB1597

pMB433-pGAL-3HA-CSE4 (2µ, URA3)

This study

BOK629

pGAL1/10-GST-SLX5

Open Biosystems
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